Literature DB >> 20166673

Histochemical application of a peroxidase DNAzyme with a covalently attached hemin cofactor.

Derek Thirstrup1, Geoffrey S Baird.   

Abstract

The enzyme horseradish peroxidase is routinely used in immunohistochemistry to facilitate the chromogenic oxidation of 3,3'-diaminobenzidine, producing an insoluble brown precipitate marking the location and quantity of a tissue protein. In an effort to develop non-protein reagents for tissue diagnostics, we have developed a peroxidase DNAzyme construct that can be used as a chromogenic functional group in immunohistochemistry assays. The DNAzyme is based on a reported 18-mer G-quadruplex-forming DNA sequence, PS2.M, and has been covalently linked to its catalytically active moiety, hemin, to avoid the high background signal associated with the use of free hemin in histochemical studies. The activity of the covalent construct is maintained under conditions where G-quadruplex formation is unfavored and where the noncovalent DNAzyme-hemin complex has no activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20166673     DOI: 10.1021/ac902887j

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  3 in total

Review 1.  G-quadruplex-based aptamers against protein targets in therapy and diagnostics.

Authors:  Chiara Platella; Claudia Riccardi; Daniela Montesarchio; Giovanni N Roviello; Domenica Musumeci
Journal:  Biochim Biophys Acta Gen Subj       Date:  2016-11-16       Impact factor: 3.770

2.  Comparison of Characteristics and DNAzyme Activity of G4⁻Hemin Conjugates Obtained via Two Hemin Attachment Methods.

Authors:  Joanna Kosman; Krzysztof Żukowski; Bernard Juskowiak
Journal:  Molecules       Date:  2018-06-09       Impact factor: 4.411

3.  Sequence Effect on the Activity of DNAzyme with Covalently Attached Hemin and Their Potential Bioanalytical Application.

Authors:  Joanna Kosman; Krzysztof Żukowski; Andrea Csáki; Wolfgang Fritzsche; Bernard Juskowiak
Journal:  Sensors (Basel)       Date:  2022-01-10       Impact factor: 3.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.